# GABAPENTIN ENCARBIL
> **ANDA213501** · Abbreviated New Drug Application (Generic) · Sponsor: GLENMARK PHARMS LTD · Approved 2020-12-29
## Drug
- **FDA Application Number:** ANDA213501
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** GABAPENTIN ENCARBIL
- **Generic name:** Gabapentin Encarbil
- **Active ingredients:** GABAPENTIN ENCARBIL
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** GLENMARK PHARMS LTD
- **First approval:** 2020-12-29
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213501)
---
*AI Analytics · CC0 1.0*